Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
DexCom, Inc. v. AgaMatrix, Inc.
Case Number:
2:16-cv-05947
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 07, 2018
AgaMatrix Gets $1.3M Fees From Dexcom's Failed IP Suit
A California federal judge has ruled that diabetes glucose monitoring company Dexcom Inc. must pay rival AgaMatrix Inc. more than $1.3 million in fees after proceeding with patent infringement litigation that bordered on bad faith.
-
May 23, 2018
Dexcom Hit With Atty Fees For 'Bad Faith' Patent Suit
Diabetes glucose monitoring company Dexcom Inc. has to pay attorneys' fees to its New Hampshire-based rival after a California federal judge held that it acted in "bad faith" by continuing to litigate a patent case despite multiple court warnings, according to an order unsealed Tuesday.